The site will be unavailable in 41 minutes for scheduled maintenance.

$28.01 -0.04 (-0.14%)
11/20/2009 4:00 PM

Dendreon Corp (DNDN)

CAPS Rating: 2 out of 5

A biotechnology company focused on the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer.

Current Price $28.01 Mkt Cap $3.25B
Open $28.56 P/E Ratio 0.00
Prev. Close $28.05 Div. (Yield) N/A (N/A)
Daily Range $27.80 - $28.68 Volume 2,715,276
52-Wk Range $2.55 - $30.42 Avg. Daily Vol. 2,564,000

DNDN News and Commentary

Caps

How do you think DNDN will perform vs the S&P 500?

Add Stock to Watchlist

All Members

1,109 Outperform
302 Underperform
 

All-Star Members

332 Outperform
97 Underperform
 

Wall Street

13 Outperform
3 Underperform
 

Top DNDN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

mullings8454 (< 20)
Submitted October 30, 2009

Whole new way of treating cancers, with treatment for breast cancer to follow treatment for prostate cancer. No more chemo or radiation. Amazing technology. Acts like a vaccine. Big companies putting big money into it, i.e. Fidelity Mutual Corp.

0 Comments | Reply | Report this Post

JGus (30.11)
Submitted May 14, 2009

Bet the wrong way on this one. Here's a good lesson for all of you...when it comes to small drug companies, most will fail because the drugs they are developing fail and they run out of money. However, those that actually survive long enough to bring… More

9 Comments | Reply | Report this Post
DNDN VS S&P 500 (SPY)

Fools bullish on DNDN are also bullish on:

Fools bearish on DNDN are also bearish on:

Recent Community Commentary

Read the most recent pitches from members about DNDN.

Recs

0
Member Avatar melj44 (50.11) Submitted: 11/12/2009 1:19:13 PM : Outperform Start Price: $28.91 DNDN Score: -3.31

New phase 3's in the works.

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar WAKEUPANDSMELL (35.43) Submitted: 11/9/2009 10:05:07 PM : Outperform Start Price: $29.20 DNDN Score: -4.19

DRUGS UNDER DEVELOPMENT

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar brianpivar (96.79) Submitted: 11/9/2009 6:29:43 PM : Underperform Start Price: $29.20 DNDN Score: +4.19

terrible fundamentals

Report this Post 0 Comments | Reply | Permalink
View All 329 Pitches »

Leaderboard

Find the members with the highest scoring picks in DNDN.

Score Leader

chd1028

chd1028 (< 20) Score: +930.30

The Score Leader is the member with the highest score across all their picks in DNDN.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		S&P
Gain 		Score Commentary
chd1028 < 20 3/9/2009 Outperform NS $2.56 +994.14% +63.84% +930.30 2 Comments
feew3339 98.39 3/6/2009 Outperform NS $2.62 +969.04% +65.04% +904.00
Bucks1977 67.69 3/6/2009 10/1/2009 Outperform 1Y $2.76 +914.86% +61.52% +853.33
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. i12Bravo 96.81 3/12/2009 6/1/2009 Outperform 1Y $2.82 +893.26% +53.35% +839.91
mojavemystic 49.39 3/12/2009 Outperform 5Y $2.83 +889.79% +52.87% +836.92
Ranoff 81.09 3/11/2009 Outperform NS $2.90 +865.86% +52.55% +813.31 1 Comment
tgga99 98.07 3/3/2009 Outperform 5Y $2.99 +836.79% +55.63% +781.16
westsider317 < 20 3/4/2009 Outperform 5Y $3.02 +827.48% +56.16% +771.33
Pooltableman17 < 20 3/2/2009 Outperform 3M $3.03 +824.42% +53.57% +770.85 1 Comment
cubaislibre 95.86 1/30/2009 Outperform 1Y $3.40 +723.82% +33.87% +689.95
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackCanaccord 78.23 10/24/2009 Outperform NS $28.52 -1.79% -0.24% -1.55
TrackLeerinkSwan 83.04 9/22/2009 Outperform NS $29.94 -6.45% +2.23% -8.68
TrackJimCramer 36.31 7/7/2009 Outperform 3W $24.02 +16.61% +24.86% -8.25
TrackCitigroup < 20 6/10/2009 Outperform NS $26.07 +7.44% +15.81% -8.37
TrackDeutscheSec 87.23 6/5/2009 Outperform NS $26.75 +4.71% +15.76% -11.05
TrackMcAdamsWrig 53.22 5/8/2009 Underperform NS $19.29 +34.01% -0.95% -34.96 6/22/2009 @ $25.85
TrackWachovia < 20 4/29/2009 Outperform NS $27.00 +3.74% +27.83% -24.08
TrackBreanMurray 87.51 4/29/2009 Outperform NS $27.00 +3.74% +27.83% -24.08
TrackNeedham < 20 4/29/2009 Outperform NS $27.00 +3.74% +27.83% -24.08
TrackMerriman < 20 4/22/2009 Outperform NS $20.57 +36.17% +31.18% +4.99
TrackLazardCapit < 20 4/20/2009 Outperform NS $18.66 +50.11% +29.26% +20.85
TrackRodmanRen < 20 4/14/2009 Outperform NS $17.37 +61.24% +30.53% +30.71
TrackZacks 70.74 4/14/2009 Outperform 3M $16.99 +64.86% +31.09% +33.78 1 Comment
TrackMerriman < 20 10/16/2008 Underperform NS $4.95 +315.56% -7.69% -323.25 4/22/2009 @ $20.57
TrackJMP < 20 7/12/2007 Underperform NS $7.88 +255.46% -24.40% -279.86
TrackBreanMurray 87.51 5/11/2007 Underperform NS $5.13 +250.88% -42.89% -293.77 4/14/2009 @ $18.00
TrackBofASec 91.37 5/10/2007 Underperform NS $5.75 +387.13% -23.25% -410.38
TrackUBS 88.39 5/8/2007 Underperform NS $17.14 +63.42% -23.15% -86.57
TrackJimCramer 36.31 5/7/2007 Underperform 3W $17.92 +34.04% -41.66% -75.70 7/8/2009 @ $24.02
TrackNextGen 49.39 5/3/2007 Outperform NS $18.13 +54.50% -22.88% +77.37
TrackJimCramer 36.31 4/5/2007 Outperform 3W $18.05 -0.72% +4.65% -5.37 5/8/2007 @ $17.92
TrackJMP < 20 3/30/2007 Outperform NS $17.92 -62.95% +7.21% -70.15 5/24/2007 @ $6.64
TrackJimCramer 36.31 3/28/2007 Underperform 3W $5.22 +245.79% +1.71% -244.08 4/6/2007 @ $18.05

Featured Broker Partners